# DialBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dialbio

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.dialbio.com.cn
- Total disclosed funding: $1.6M
- Latest round: Angel (Oct 20, 2021)
- Investors on record: 1

## About

Founded in 2021 and based in Shanghai, China, DialBio is a biotech company that provides biological drug R&D and clinical translational research services. The company has a biological analysis laboratory, a qPCR P2 laboratory, a cell biology laboratory, etc., as well as an SPF-level small animal room. Ying Jiang, the founder of the company, has 15 years of drug R&D experience in internationally renowned pharmaceutical companies (Johnson & Johnson, Merck & Co.) and 13 years of domestic well-known CRO drug R&D service management experience.

The company's main business is to provide end-to-end integrated translational research services for innovative biological drugs from pharmacodynamics to clinical analysis and testing, including central laboratory functions that comply with GLP&GCP quality management standards, clinical and preclinical biological sample analysis Testing, pharmacodynamics, tumor immune analysis and other services.

## Funding rounds

- Angel, Oct 20, 2021, $1.6M — Huaige Capital

## Investors

- Huaige Capital (https://capitalatlas.ai/funds/huaige-capital) — Angel